FROM MOLECULE...TO HUMAN
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Platforms ＆ installations
IBiSA labelled platform since January 2013
Scientific managementMatthieu GÉRARD (Researcher, CEA)
Guillaume PINNA (Researcher, CEA)Gueorgui KRATASSIOUK (Research Ingeneer, CNRS)Marie VANDAMME (Technician, CEA)
BioinformaticNadya MOROZOVA (Research Ingeneer, CNRS)
The PARi platform ("Platform RNA interference") is a screening technological platform dedicated to broadband functional genomics on human cell lines. It is located in the Integrative Biology and Molecular Genetics unit (SBIGeM).
CNRS, CEA, InCa, ANR, IBisa, Ligue Nationale contre le Cancer, Réseau National des Génopoles, ARC, AFM.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.